Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56


Characterization of oligomers induced by inverse agonists of CTLA-4.

Teft WA, Madrenas J.

Immunol Lett. 2008 Oct 30;120(1-2):29-36. doi: 10.1016/j.imlet.2008.06.005. Epub 2008 Jul 15.


Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.

Darlington PJ, Kirchhof MG, Criado G, Sondhi J, Madrenas J.

J Immunol. 2005 Jul 15;175(2):996-1004.


B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties.

Bhatia S, Edidin M, Almo SC, Nathenson SG.

Immunol Lett. 2006 Apr 15;104(1-2):70-5. Epub 2005 Dec 13. Review.


A theoretical framework for quantitative analysis of the molecular basis of costimulation.

Jansson A, Barnes E, Klenerman P, Harlén M, Sørensen P, Davis SJ, Nilsson P.

J Immunol. 2005 Aug 1;175(3):1575-85.


Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling.

Bhatia S, Edidin M, Almo SC, Nathenson SG.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15569-74. Epub 2005 Oct 12.


Structure-Function analysis of the CTLA-4 interaction with PP2A.

Teft WA, Chau TA, Madrenas J.

BMC Immunol. 2009 Apr 30;10:23. doi: 10.1186/1471-2172-10-23.


Expression of CD86 on human islet endothelial cells facilitates T cell adhesion and migration.

Lozanoska-Ochser B, Klein NJ, Huang GC, Alvarez RA, Peakman M.

J Immunol. 2008 Nov 1;181(9):6109-16.


CTLA-4 interacts with STAT5 and inhibits STAT5-mediated transcription.

Srahna M, Van Grunsven LA, Remacle JE, Vandenberghe P.

Immunology. 2006 Mar;117(3):396-401.


CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis.

Laurent S, Palmisano GL, Martelli AM, Kato T, Tazzari PL, Pierri I, Clavio M, Dozin B, Balbi G, Megna M, Morabito A, Lamparelli T, Bacigalupo A, Gobbi M, Pistillo MP.

Br J Haematol. 2007 Feb;136(4):597-608.


Regulation of CD28 expression on CD8+ T cells by CTLA-4.

Berg M, Zavazava N.

J Leukoc Biol. 2008 Apr;83(4):853-63. Epub 2007 Dec 27.


Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.

Jin ZX, Huang CR, Dong L, Goda S, Kawanami T, Sawaki T, Sakai T, Tong XP, Masaki Y, Fukushima T, Tanaka M, Mimori T, Tojo H, Bloom ET, Okazaki T, Umehara H.

Int Immunol. 2008 Nov;20(11):1427-37. doi: 10.1093/intimm/dxn100. Epub 2008 Sep 26.


Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells.

Crotta S, Ronconi V, Ulivieri C, Baldari CT, Valiante NM, Abrignani S, Wack A.

Eur J Immunol. 2006 Apr;36(4):919-29. Erratum in: Eur J Immunol. 2006 May;36(5):1350. Valiente, Nicholas M [corrected to Valiante, Nicholas M].


Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells.

Mead KI, Zheng Y, Manzotti CN, Perry LC, Liu MK, Burke F, Powner DJ, Wakelam MJ, Sansom DM.

J Immunol. 2005 Apr 15;174(8):4803-11.


Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.

Shieh SJ, Chou FC, Yu PN, Lin WC, Chang DM, Roffler SR, Sytwu HK.

J Immunol. 2009 Aug 15;183(4):2277-85. doi: 10.4049/jimmunol.0900679. Epub 2009 Jul 27.


Two different forms of human CTLA-4 proteins following peripheral T cell activation.

Chun T, Choi HJ, Chung YH.

Immunol Lett. 2004 Feb 15;91(2-3):213-20.


T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor.

Valk E, Leung R, Kang H, Kaneko K, Rudd CE, Schneider H.

Immunity. 2006 Nov;25(5):807-21. Epub 2006 Oct 26.


CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.

Kolar P, Knieke K, Hegel JK, Quandt D, Burmester GR, Hoff H, Brunner-Weinzierl MC.

Arthritis Rheum. 2009 Jan;60(1):123-32. doi: 10.1002/art.24181.


CTLA-4 control over Foxp3+ regulatory T cell function.

Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S.

Science. 2008 Oct 10;322(5899):271-5. doi: 10.1126/science.1160062.


Cytotoxic T-lymphocyte-associated antigen-4.

Hodi FS.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5238-42. Review.

Supplemental Content

Support Center